Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion

Nakhai-Pour, Hamid Reza; Broy, Perrine; Sheehy, Odile; Brard, Anick
October 2011
CMAJ: Canadian Medical Association Journal;10/18/2011, Vol. 183 Issue 15, p1713
Academic Journal
Background: The association between the use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy and the risk of spontaneous abortion remains unclear because of inconsistent research results and the lack of evidence for an effect due to specific types or dosages of nonaspirin NSAIDs. We aimed to quantify the association between having a spontaneous abortion and types and dosages of nonaspirin NSAIDs in a cohort of pregnant women. Methods: Using a nested case-control design, we obtained data from the Quebec Pregnancy Registry for 4705 women who had a spontaneous abortion. For each instance, we randomly selected 10 controls from the remaining women in the registry who were matched by index date (date of the spontaneous abortion) and gestational age. Use of nonaspirin NSAIDs (identified by filled prescriptions) and nonuse were compared. We also looked for associations between different types and dosages of nonaspirin NSAIDs and having a spontaneous abortion. Analyses of associations and adjustment for confounding were done using conditional logistic regression. Results: We identified 4705 cases of spontaneous abortion (352 exposed [7.5%]); 47 050 controls (1213 exposed [2.6%]). Adjusting for potential confounders, the use of nonaspirin NSAIDs during pregnancy was significantly associated with the risk of spontaneous abortion (odds ratio [OR] 2.43, 95% confidence interval [CI] 2.12-2.79). Specifically, use of diclofenac (OR 3.09, 95% CI 1.96-4.87), naproxen (OR 2.64, 95% CI 2.13-3.28), celecoxib (OR 2.21, 95% CI 1.42-3.45), ibuprofen (OR 2.19, 95% CI 1.61-2.96) and rofecoxib (OR 1.83, 95% CI 1.24-2.70) alone, and combinations thereof (OR 2.64, 95% CI 1.59-4.39), were all associated with increased risk of spontaneous abortion. No dose-response effect was seen. Interpretation: Gestational exposure to any type or dosage of nonaspirin NSAIDs may increase the risk of spontaneous abortion. These drugs should be used with caution during pregnancy.


Related Articles

  • NSAIDs at conception raise miscarriage risk. Polak, Monika // GP: General Practitioner;8/18/2003, p4 

    Researchers of Oakland, California-based Kaiser Research Foundation Institute have found that risk of miscarriage almost doubled for women who took NSAIDs during pregnancy. They also found similar associations between prenatal aspirin use and miscarriage, but concluded the risk estimates were...

  • NSAIDs more than double risk of spontaneous abortion.  // Reactions Weekly;9/17/2011, Issue 1369, p1 

    The article reports on a study which revealed that use of any type or dosage of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy more than doubles the risk of spontaneous abortion.

  • NSAIDs in early pregnancy double risk of miscarriage.  // Pulse;9/14/2011, Vol. 71 Issue 29, p14 

    The article offers information on a study regarding the risk of miscarriage among users of non-aspirin nonsteroidal anti-inflammatory agents (NSAID) in early pregnancy which double compared with women who do not take the drugs in Quebec.

  • The Influence of Antiphospholipid Antibodies on the Pregnancy Outcome of Patients With Recurrent Spontaneous Abortion. Heilmann, L.; Tempelhoff, G.-F. V.; Kuse, S. // Clinical & Applied Thrombosis/Hemostasis;Oct2001, Vol. 7 Issue 4, p281 

    Several therapeutic regimens have been proposed for women with recurrent spontaneous abortion (RSA) and antiphospholipid antibodies (APA). Conflicting results have been reported about women with history of RSA, positive APA, and failure of standard therapy. To evaluate the use of intravenous...

  • NSAIDs do not raise the risk of miscarriage.  // Clinical Advisor;Mar2014, Vol. 17 Issue 3, p30 

    No abstract available.

  • NSAID use raises risk of birth defects.  // Pulse;8/10/2006, Vol. 66 Issue 31, p3 

    The article reports that taking non-steroidal anti-inflammatory drugs during pregnancy increases the risk of certain birth defects by up to five-fold. The risk could be highest in the first trimester. There is also risk of cardiac septal defects in the newborns of NSAID users aside from...

  • NSAID use in first trimester may increase risk of congenital anomalies.  // Formulary;Dec2006, Vol. 41 Issue 12, p624 

    The article presents a study on the risk of nonsteroidal anti-inflammatory drugs (NSAID) in early pregnancy of the woman. The study revealed that the use of NSAID during the first trimester of a pregnant woman can increase risk of giving birth to a child with congenital anomalies particularly...

  • Successful perinatal outcome following recurrent idiopathic cerebrovascular strokes in pregnancy: a case report. Nanda, Smiti; Agarwal, Umber; Sangwan, Krishna // Archives of Gynecology & Obstetrics;Aug2003, Vol. 268 Issue 3, p236 

    A 25-year-old gravida 2 had two right cerebral hemispheric infarcts documented on magnetic resonance imaging (MRI) and computed tomography (CT) scan at 23 and 31 weeks of pregnancy. Investigations failed to reveal any cause. She was empirically treated with heparin, aspirin and nimodipine and...

  • …Should I take aspirin to prevent preeclampsia? Funai, Edmund F. // Contemporary OB/GYN;Aug2007, Vol. 52 Issue 8, p34 

    The article explores the safety of administering aspirin to pregnant women to prevent preeclampsia. It offers a definition of preeclampsia and describes its seriousness. It examines the potential preventative effects of low-dose aspirin on preeclampsia. It cites the findings of the Perinatal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics